Frequently Asked Questions—

Chronic Diseases

Chronic Diseases FAQ Innate Healthcare Institute

*These statements have not been evaluated by the FDA. Innate Healthcare Institute is a private clinic and any treatments utilizing any form of regenerative medicine is considered experimental.

How long have you been doing treatments for these conditions?
In 2018, after experiencing resounding success in the orthopedic field of regenerative medicine, Innate Healthcare Institutes founder Dr. Travis Whitney noticed most of all the current regenerative medicine clinics in the United states had poor solutions for chronic diseases. The research using umbilical cord derived mesenchymal stem cells showed significant improvements in many chronic diseases, however the clinics around the United States we’re using watered-down, commercially available biological products that didn’t reflect what the research was doing. A new approach needed to come forward to take on the growing hardship of chronic diseases in the United States. In addition to using high doses of umbilical cord mesenchymal stem cells that more closely reflects the successful research, an integrative and holistic approach is also implemented to cover the most comprehensive treatment possible. We’ve been treating a variety of chronic diseases since 2018 and are continually growing our repertoire of conditions.
Why is mannitol used in some of the IVs for neurological conditions before UC-MSC delivery?
Mannitol is used for neurological conditions as an osmotic diuretic to reduce intracranial pressure (ICP) and improve cerebral perfusion. By decreasing brain swelling and improving cerebral perfusion, mannitol creates a more favorable environment for the delivery and distribution of umbilical cord stem cells. This can potentially enhance the therapeutic benefits of the stem cells and improve the outcome of the therapy. It works by drawing water out of the brain and into the bloodstream, decreasing brain swelling, and improving blood flow.

The standard dose of IV mannitol to increase blood-brain barrier permeability is typically 20% mannitol solution, 1-2 g/kg body weight, while the pediatrics dose is 0.25–1.0 g/kg, infused over 10-20 minutes. It is important to note that the exact dose and duration may vary based on the patient’s condition and other factors and should always be determined by a healthcare professional.

What chronic diseases is UC-MSC therapy able to treat?

UC-MSC (Umbilical Cord Mesenchymal Stem Cells) is growing to be a promising treatment for a variety of inflammatory, chronic conditions. UC-MSC therapy has shown potential in treating various chronic diseases such as:

  1. Autoimmune disorders, like rheumatoid arthritis, lupus, and multiple sclerosis
  2. Neurological conditions, like Parkinson’s disease, Alzheimer’s disease, and spinal cord injury
  3. Cardiovascular disease, like heart failure and myocardial infarction
  4. Lung diseases, like chronic obstructive pulmonary disease and acute respiratory distress syndrome
  5. Kidney diseases, like nephrotic syndrome and end-stage renal disease
  6. Autism and similar developmental disorders
  7. Neuropathy conditions, like diabetic neuropathy, carpel tunnel syndrome, and peripheral neuropathy.

This list is continually evolving. If you have a condition you feel could benefit from UC-MSC therapy please call us to find out more

What conditions are contraindicated in UC-MSC therapy?

The use of umbilical cord mesenchymal stem cells (UC-MSCs) for therapeutic purposes is still an experimental field, and more research is needed to fully understand the safety and efficacy of these cells as a treatment for various medical conditions. However, based on the current available evidence, there are some conditions that may be contraindicated for UC-MSC therapy.
Some conditions that may be contraindicated, or caution should be used, for UC-MSC therapy include:

  1. Cancer (Contraindicated): UC-MSCs have the potential to divide and differentiate into various types of cells, including cancer cells. Therefore, it’s important to be cautious when using UC-MSCs in patients with a history of cancer or with an active malignancy, as they may pose a risk of tumor formation. Especially Melanoma.
  2. Immunological disorders (Caution): UC-MSCs have the potential to suppress the immune system, and therefore, it’s important to be cautious when using UC-MSCs in patients with immunological disorders, as they may pose a risk of exacerbating these conditions.
  3. Autoimmune diseases (Caution): UC-MSCs have the potential to suppress the immune system, and therefore, it’s important to be cautious when using UC-MSCs in patients with autoimmune diseases, as they may pose a risk of exacerbating these conditions.
  4. Bleeding disorders (Caution): UC-MSC therapy may pose a risk of bleeding and hematoma formation, and therefore, it’s important to be cautious when using UC-MSCs in patients with bleeding disorders.
  5. Infections (Caution): Severe infections could be affected if a stem cell treatment suppresses the immune system. It’s important to ensure that UC-MSCs are obtained from reputable sources and that they are screened for infectious agents before they are used for therapeutic purposes.

These are general contraindications, and it’s important to consult with a qualified healthcare professional at Innate Healthcare Institute before considering treatment with UC-MSCs, as there may be other factors that need to be considered based on a person’s individual medical history and health status.

Chronic Diseases FAQ Innate Healthcare Institute

We’d love to hear from you.

Don’t see your question? Click the button below to contact us. If you prefer immediate assistance, please call us at 602-603-3118.